Facebook
Twitter
Telegram
Report an ErrorVivos Therapeutics Financial Statements 2011-2024 | VVOS
Annual Financial Statements Vivos Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
5.89 M | 322 K | 70.9 B | 116 M | - | - | - | - | - | - | - | - | - |
Shares |
1.22 M | 921 K | 21.2 B | 17.7 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
4.83 | 0.35 | 3.34 | 7.51 | - | - | - | - | - | - | - | - | - |
Net Income |
-13.6 M | -23.8 M | -20.3 M | -12.1 M | -10.8 M | -8.44 M | - | - | - | - | - | - | - |
Revenue |
13.8 M | 16 M | 16.9 M | 13.1 M | 11.4 M | 3.79 M | - | - | - | - | - | - | - |
Cost of Revenue |
200 K | 200 K | 400 K | 100 K | 2.74 M | - | - | - | - | - | - | - | - |
Gross Profit |
8.27 M | 10 M | 12.6 M | 10.4 M | 8.66 M | 2.71 M | - | - | - | - | - | - | - |
Operating Income |
-17.3 M | -25 M | -20.4 M | -12 M | -10.6 M | - | - | - | - | - | - | - | - |
Interest Expense |
-212 K | -190 K | 14 K | 96 K | 138 K | - | - | - | - | - | - | - | - |
EBITDA |
-16.7 M | -24.4 M | -19.6 M | -7.99 M | -9.83 M | -7.73 M | - | - | - | - | - | - | - |
Operating Expenses |
25.6 M | 35 M | 33 M | 19.1 M | 19.2 M | 11 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
22.5 M | 29 M | 25.8 M | 16.1 M | 16.2 M | 9.27 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Vivos Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
2.31 M | 1.83 M | 1.2 M | 29.9 M | 991 K | 921 K | 849 K | 21.2 M | 21.2 M | 23 M | 20.8 B | 20.7 B | 18.2 M | 18.2 M | 12.5 M | 12.5 M | 12.5 M | 12.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-3.76 M | - | -2.09 M | -5.53 M | -1.7 M | - | -5.43 M | -6.99 M | -5.33 M | - | -5.45 M | -4.04 M | -3.4 M | - | -1.81 M | -1.41 M | -2.58 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
3.42 M | - | 3.3 M | 3.4 M | 3.86 M | - | 4.25 M | 4.18 M | 3.46 M | - | 4.55 M | 4.5 M | 7.74 K | - | 21 K | 21.7 K | 20.9 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
100 K | - | 100 K | 100 K | 100 K | - | 100 K | 100 K | 100 K | - | 100 K | 100 K | 100 K | - | 709 K | 545 K | 780 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
1.94 M | - | 1.9 M | 2.1 M | 2.34 M | - | 2.5 M | 2.59 M | 2.37 M | - | 3.18 M | 3.62 M | 2.69 M | - | 2.58 M | 2.73 M | 2.42 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-3.78 M | - | -3.49 M | -4.52 M | -5 M | - | -5.41 M | -6.96 M | -6.82 M | - | -5.5 M | -4.06 M | -3.41 M | - | -1.82 M | -1.42 M | -2.56 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
-1 K | - | -53 K | -225 K | 51 K | - | -36 K | -37 K | - | - | 9.49 K | 251 | 82 | - | 17 K | 18.1 K | 43.7 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-3.64 M | - | -3.34 M | -4.37 M | -4.83 M | - | -5.23 M | -6.8 M | -6.78 M | - | -4.94 M | -3.69 M | -3.23 M | - | -1.64 M | -1.24 M | -2.38 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
5.72 M | - | 5.39 M | 6.62 M | 7.34 M | - | 7.9 M | 9.55 M | 9.19 M | - | 8.69 M | 7.68 M | 6.1 M | - | 4.4 M | 4.14 M | 4.97 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
4.92 M | - | 4.6 M | 5.88 M | 6.54 M | - | 6.62 M | 7.69 M | 8.28 M | - | 6.52 M | 6.09 M | 5.06 M | - | 3.79 M | 3.46 M | 4.23 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency